web analytics
April 23, 2014 / 23 Nisan, 5774
At a Glance

Posts Tagged ‘Pfizer’

Parkinson’s Study Will Look at Ashkenazi Jewish Genetic Mutation

Thursday, February 27th, 2014

A study sponsored by The Michael J. Fox Foundation for Parkinson’s Research will investigate a genetic mutation found more often in Ashkenazi Jews.

The Parkinson’s Progression Markers Initiative, a large-scale biomarker study, is expanding to study individuals with genetic mutations associated with Parkinson’s disease. Among those mutations is the LRRK2, which accounts for a greater number of Parkinson’s cases among certain ethnic populations and families, notably Jews of Eastern European descent.

The study will enroll 250 people with the LRRK2 mutation and Parkinson’s and a like number with the mutation but without Parkinson’s.

Genetic mutations account for 5 percent to 10 percent of all Parkinson’s cases, but a study of these individuals may reveal disease traits that apply to all Parkinson’s patients.

The Fox Foundation has secured 15 industry partners and co-funding sponsors for the initiative. They include Abbott Laboratories, Biogen, BMS, Covance, Eli Lilly, GE Healthcare, Genentech, GSK, Merck, Pfizer and Roche.

The study will take place at 32 clinical sites around the world.

Teva to Sell Generic Viagra in UK, and Move Patent Filing to Switzerland

Sunday, June 23rd, 2013

Teva, the world leader in generic medication will be soon be launching a generic version of Pfizer’s Viagra in the UK and Europe.

Pfizer’s Viagra patents expired this past week in the UK and parts of Europe, allowing other manufacturers to move in.

In the US, a court ruling has prevented Teva from introducing generic Viagra until at least 2020.

Teva also announced that it will stop filing its patents in Israel, and will now be filing them instead in Switzerland.

The reason for the move are Switzerland’s patent related tax laws, and subsequent tax breaks and benefits they will provide Teva.

Teva said that if Israel were to change its tax codes to make them more competitive with other countries, they’d be happy to move the IP registrations back to Israel, according to a report in Globes.

Printed from: http://www.jewishpress.com/news/breaking-news/teva-to-sell-generic-viagra-in-uk-and-move-patents-to-switzerland/2013/06/23/

Scan this QR code to visit this page online: